OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent updates of fluoroquinolones as antibacterial agents
Hend A. A. Ezelarab, Samar H. Abbas, Abdelfattah Hassan, et al.
Archiv der Pharmazie (2018) Vol. 351, Iss. 9
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Morena Zusso, Valentina Lunardi, Davide Franceschini, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 388

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics
Bismillah Mubeen, Aunza Nayab Ansar, Rabia Rasool, et al.
Antibiotics (2021) Vol. 10, Iss. 12, pp. 1473-1473
Open Access | Times Cited: 157

1,2,4-Triazoles as Important Antibacterial Agents
Małgorzata Strzelecka, Piotr Świątek
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 224-224
Open Access | Times Cited: 135

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Stephen Wood, Timothy M. Kuzel, Sasha H. Shafikhani
Cells (2023) Vol. 12, Iss. 1, pp. 199-199
Open Access | Times Cited: 129

Difunctional covalent organic framework hybrid material for synergistic adsorption and selective removal of fluoroquinolone antibiotics
Wei Jiang, Wei‐Rong Cui, Ru‐Ping Liang, et al.
Journal of Hazardous Materials (2021) Vol. 413, pp. 125302-125302
Closed Access | Times Cited: 103

Photocatalytic Degradation of Some Typical Antibiotics: Recent Advances and Future Outlooks
Xue Bai, Wanyu Chen, Bao Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8130-8130
Open Access | Times Cited: 101

Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 78

Quinoline Hydrazide/Hydrazone Derivatives: Recent Insights on Antibacterial Activity and Mechanism of Action
Sangeeta Verma, Sukhbir Lal, Rakesh Narang, et al.
ChemMedChem (2023) Vol. 18, Iss. 5
Closed Access | Times Cited: 51

Recent advances in the synthetic and medicinal perspective of quinolones: A review
Prashant Dhiman, Nidhi Arora, Punniyakoti T. Veeraveedu, et al.
Bioorganic Chemistry (2019) Vol. 92, pp. 103291-103291
Closed Access | Times Cited: 123

Levofloxacin-based carbon dots to enhance antibacterial activities and combat antibiotic resistance
Lina Wu, Yuan-Jie Yang, Lin-Xiao Huang, et al.
Carbon (2021) Vol. 186, pp. 452-464
Closed Access | Times Cited: 89

Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance
Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 59

The antibacterial activity of fluoroquinolone derivatives: An update (2018–2021)
Yanshu Jia, Liyan Zhao
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113741-113741
Closed Access | Times Cited: 56

A review: Structure-activity relationship and antibacterial activities of Quinoline based hybrids
Kajalben B. Patel, Premlata Kumari
Journal of Molecular Structure (2022) Vol. 1268, pp. 133634-133634
Closed Access | Times Cited: 45

Antimicrobial Photodynamic Therapy for the Remote Eradication of Bacteria
Evelias Yan, Germain Kwek, Ng Shuang Qing, et al.
ChemPlusChem (2023) Vol. 88, Iss. 3
Open Access | Times Cited: 29

Topoisomerase II inhibitors design: Early studies and new perspectives
Hadeer K. Swedan, Asmaa E. Kassab, Ehab M. Gedawy, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106548-106548
Closed Access | Times Cited: 25

The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy
Asiyeh Avakh, Gary Grant, Matthew James Cheesman, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 25

High risk for life-threatening adverse events of fluoroquinolones in young adults: a large German population-based cohort study
Julia Wicherski, Jonas Peltner, Cornelia Becker, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Sexually Transmitted Infections (STIs)
Rodrigo M Burgos
The American Pharmacists Association eBooks (2017)
Closed Access | Times Cited: 73

Antimicrobial Agents and Urinary Tract Infections
Lernik Issakhanian, Payam Behzadi
Current Pharmaceutical Design (2019) Vol. 25, Iss. 12, pp. 1409-1423
Closed Access | Times Cited: 61

Towards anticancer fluoroquinolones: A review article
Mohamed A. A. Abdel‐Aal, Salah A. Abdel‐Aziz, Montaser Sh. A. Shaykoon, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 7
Closed Access | Times Cited: 54

The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux
Julia Vergalli, Alessio Atzori, Jelena Pajović, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 52

Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Abdourahamane Yacouba, Ahmed Olowo‐okere, Ismaeel Yunusa
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 52

Outcome of Different Sequencing and Assembly Approaches on the Detection of Plasmids and Localization of Antimicrobial Resistance Genes in Commensal Escherichia coli
Katharina Juraschek, Maria Borowiak, Simon H. Tausch, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 598-598
Open Access | Times Cited: 41

Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections
Joshua C. Nwabuife, Calvin A. Omolo, Thirumala Govender
Journal of Controlled Release (2022) Vol. 349, pp. 338-353
Closed Access | Times Cited: 30

Page 1 - Next Page

Scroll to top